Chemotherapeutic deletion of CTG repeats in lymphoblast cells from DM1 patients

Keyphrases

• Repeat Expansion 100%
• Lymphoblast 100%
• CTG Repeat 100%
• Disease Severity 66%
• CAG Repeat 66%
• Ethyl Methanesulfonate 66%
• Mitoxantrone 33%
• Cell Population 33%
• Germ Cells 33%
• Disease Onset 33%
• Neurological Diseases 33%
• Doxorubicin 33%
• Therapeutic Approaches 33%
• Drug-induced 33%
• Myotonic Dystrophy 33%
• Mitomycin C 33%
• Genetic mutation 33%
• Disease Class 33%
• DNA Repeats 33%
• Chromosome 19q13.3 33%
• Therapeutic Concentrations 33%
• Repeat Length 33%
• Expanded Repeats 33%
• DMPK Gene 33%

Neuroscience

• CAG Repeat 100%
• Lymphoblast 100%
• Cell Line 50%
• Nervous System Disorder 50%
• Germ Cell 50%
• Somatics 50%
• Gene Mutation 50%
• Doxorubicin 50%
• Mitomycin 50%
• Myotonic Dystrophy 50%
• Mitoxantrone 50%
• Repeated Sequence (DNA) 50%

Biochemistry, Genetics and Molecular Biology

• CAG Repeat 100%
• Lymphoblast 100%
• Gene Mutation 50%
• Germline 50%
• Germ Cell 50%
• Repeated Sequence (DNA) 50%
• Doxorubicin 50%